ReviewPharmaceutics2024

T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma.

Robin Reschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.